Design and in vitro evaluation of mucoadhesive buccal films containing famotidine

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue SUPPL. 3, 2010, Pages 86-90

  Kumar, Manish ^a   Garg, Garima ^a   Kumar, Pushpendra ^a   Kulkarni, G T ^a   Kumar, Arun ^a  

^a NKBR College of Pharmacy and Research Centre   (India)

Author keywords

Buccal patches; Evaluation; Famotidine; In vitro release

Indexed keywords

FAMOTIDINE; PHOSPHATE BUFFERED SALINE;

ADHESION; ARTICLE; DRUG ADMINISTRATION ROUTE; DRUG DESIGN; DRUG RELEASE; DRUG SCREENING; ENDURANCE; FILM COATING; FOURIER TRANSFORMATION; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; INFRARED SPECTROSCOPY; NORMAL HUMAN; PH; PHYSICAL CHEMISTRY; TENSILE STRENGTH;

EID: 77957600189     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Anders R and Merkle HP (1989). Evaluation of laminated mucoadhesive patches for buccal drug delivery. Int. J. Pharm., 34: 498-502.
2. Balamurugan K, Pandit JK, Choudary PK and Balasubramaniam J (2001). Systemic absorption of propranolol hydrochloride from buccoadhesive films. Ind. J. Pharm. Sci., 63: 473-480.
3. Barsuhn CL, Planoff LS, Gleason DD, Adkins EL and Ho NFH (1988). Human buccal absorption of flurbiprofen. Clin. Pharmacol. Ther., 44: 225-231.
4. Beckett AH and Triggs EJ (1967). Buccal absorption of basic drugs and its application as an in vivo model of passive drug transfer through lipid membranes. J. Pharm. Pharmacol., 19: 31s-41s.
5. Borodkin S and Tucker FE (1974). Drug release from hydroxy propyl cellulose-polyvinyl acetate films. J.Pharm. Sci., 9: 13591364.
6. Choy FW, Kah HY and Kok KP (1999) Formulation and evaluation of controlled release eudragit buccal patches. Int. J. Pharm., 178: 11-22.
7. Coutel-Ergos A, Maitani Y, Veillard M, Machida Y and Nagai T (1992). Combined effects of pH, cosolvent and penetration enhancers on the in vitro buccalabsorption of propranolol through excised Hamster cheek pouch. Int. J. Pharm., 84: 117128.
8. Edith M, Donald EC and Claus ML (1999). Bioadhesive Drug Delivery Systems. Marcel Dekker Inc., New York, pp. 541-562.
9. Gua JH and Cooklock KM (1995). Bioadhesive Polymer buccal patches for buprenorphine controlled delivery: Solubility Consideration. Drug Devel. Ind. Pharm.,21: 2013-2019.
10. Guo JH (1994). Bioadhesive polymer buccal patches for buprenorphine controlled delivery: Formulation in vitro adhesion and release properties. Drug Dev. Ind.Pharm., 20: 2809-2821.
11. Khanna R, Agrawal SP and Ahuja A (1997). Preparation and evaluation of buccal films of clotrimazole for oral Candida infections. Ind. J.Pharm. Sci., 59: 299-305.
12. Michael JR, Gilles P and Firoz AG (1996). Oral Mucosal Drug Delivery. Marcel Dekker Inc., New York,74: 233-234.
13. Michael V (1998). Famotidine, a new agent for chronic heart failure. J. Pharm. Soc. Wisconsin, 2: 31-36.
14. Mollendorff EV, Reiff K and Neugebauer G (1987). Pharmacokinetics and bioavailability of famotidine, a vasodilating beta-blocker. Eur. J. Clin. Pharmacol., 33(5): 511513.
15. Noha AN, Nabila AB, Fatima A, Ismail and Lobna MM (2003). Design and characterization of mucoadhesive buccal patches containing cetylpyridium chloride. Pharm. Acta Helvetiae., 53: 199-212.
16. Patil JS and Rao KP (2003). Design and evaluation of mucoadhesive buccal patches of diclofenac sodium. Ind. J. Pharm. Sci., 4: 420-422.
17. Pavankumar GV, Ramakrishna V, Wiiliam J and Konde A (2005). Formulation and evaluation of buccal films of salbutamol sulphate. Ind. J. Pharm. Sci., 2: 160-164.
18. Siegel IA, Izutsu KT and Watson E (1981). Mechanisms of non-electrolyte penetration across dog and rabbit oral mucosa in vitro. Arch. OralBiol., 26: 357-361.
19. Thimmasetty J, subrahmanyam CVS, Manish kumar DS, Manjunath K and Shivanand K (2007). Designand evaluation of fexofenadine HCl buccl mucoadhesive patches. Biomed, 2: 73-83.